{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Syndrome d'immunodéficience acquise : Questions médicales les plus fréquentes",
"headline": "Syndrome d'immunodéficience acquise : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Syndrome d'immunodéficience acquise : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-17",
"dateModified": "2026-05-07",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Syndrome d'immunodéficience acquise"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Infections à VIH",
"url": "https://questionsmedicales.fr/mesh/D015658",
"about": {
"@type": "MedicalCondition",
"name": "Infections à VIH",
"code": {
"@type": "MedicalCode",
"code": "D015658",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.673.480"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Syndrome d'immunodéficience acquise",
"alternateName": "Acquired Immunodeficiency Syndrome",
"code": {
"@type": "MedicalCode",
"code": "D000163",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Chao Chen",
"url": "https://questionsmedicales.fr/author/Chao%20Chen",
"affiliation": {
"@type": "Organization",
"name": "Department of Ophthalmology, Beijing YouAn Hospital, Capital Medical University, Beijing, 100069, China."
}
},
{
"@type": "Person",
"name": "Kui-Fang Du",
"url": "https://questionsmedicales.fr/author/Kui-Fang%20Du",
"affiliation": {
"@type": "Organization",
"name": "Department of Ophthalmology, Beijing YouAn Hospital, Capital Medical University, Beijing, 100069, China."
}
},
{
"@type": "Person",
"name": "Lian-Yong Xie",
"url": "https://questionsmedicales.fr/author/Lian-Yong%20Xie",
"affiliation": {
"@type": "Organization",
"name": "Department of Ophthalmology, Beijing YouAn Hospital, Capital Medical University, Beijing, 100069, China."
}
},
{
"@type": "Person",
"name": "Tai-Yi Jiang",
"url": "https://questionsmedicales.fr/author/Tai-Yi%20Jiang",
"affiliation": {
"@type": "Organization",
"name": "Department of Infectious Diseases, Beijing YouAn Hospital, Capital Medical University, Beijing, 100069, China."
}
},
{
"@type": "Person",
"name": "Wen-Jun Kong",
"url": "https://questionsmedicales.fr/author/Wen-Jun%20Kong",
"affiliation": {
"@type": "Organization",
"name": "Department of Ophthalmology, Beijing YouAn Hospital, Capital Medical University, Beijing, 100069, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Molecular identification of Histoplasma capsulatum in patients with disseminated histoplasmosis and acquired immunodeficiency syndrome.",
"datePublished": "2024-09-09",
"url": "https://questionsmedicales.fr/article/39258695",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1590/0001-3765202420231287"
}
},
{
"@type": "ScholarlyArticle",
"name": "Uncovering the forgotten story of the impact of Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome on economic growth in Ghana: A gender analysis.",
"datePublished": "2023-06-23",
"url": "https://questionsmedicales.fr/article/37353922",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/hpm.3675"
}
},
{
"@type": "ScholarlyArticle",
"name": "Clinical features of Cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome and efficacy of the current therapy.",
"datePublished": "2023-05-26",
"url": "https://questionsmedicales.fr/article/37305416",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fcimb.2023.1107237"
}
},
{
"@type": "ScholarlyArticle",
"name": "Metagenomic next-generation sequencing for rapid detection of pulmonary infection in patients with acquired immunodeficiency syndrome.",
"datePublished": "2023-07-10",
"url": "https://questionsmedicales.fr/article/37430367",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12941-023-00608-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Factors Associated with Late Diagnosis of Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS) in a University Hospital in Brazil: Challenges to Achieving the 2030 Target.",
"datePublished": "2023-10-17",
"url": "https://questionsmedicales.fr/article/37896874",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/v15102097"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système immunitaire",
"item": "https://questionsmedicales.fr/mesh/D007154"
},
{
"@type": "ListItem",
"position": 3,
"name": "Déficits immunitaires",
"item": "https://questionsmedicales.fr/mesh/D007153"
},
{
"@type": "ListItem",
"position": 4,
"name": "Infections à VIH",
"item": "https://questionsmedicales.fr/mesh/D015658"
},
{
"@type": "ListItem",
"position": 5,
"name": "Syndrome d'immunodéficience acquise",
"item": "https://questionsmedicales.fr/mesh/D000163"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Syndrome d'immunodéficience acquise - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Syndrome d'immunodéficience acquise",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-11",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Syndrome d'immunodéficience acquise",
"description": "Comment le SIDA est-il diagnostiqué ?\nQuels tests sont utilisés pour le VIH ?\nQuand faut-il se faire dépister pour le VIH ?\nQuels sont les critères de diagnostic du SIDA ?\nLe SIDA peut-il être diagnostiqué sans symptômes ?",
"url": "https://questionsmedicales.fr/mesh/D000163#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Syndrome d'immunodéficience acquise",
"description": "Quels sont les symptômes du SIDA ?\nLe SIDA cause-t-il des symptômes immédiats ?\nComment les symptômes évoluent-ils ?\nY a-t-il des symptômes spécifiques aux infections opportunistes ?\nLe SIDA affecte-t-il le système nerveux ?",
"url": "https://questionsmedicales.fr/mesh/D000163#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Syndrome d'immunodéficience acquise",
"description": "Comment prévenir le SIDA ?\nLe vaccin contre le VIH existe-t-il ?\nQu'est-ce que la prophylaxie pré-exposition (PrEP) ?\nLes transfusions sanguines sont-elles sûres ?\nComment réduire le risque de transmission ?",
"url": "https://questionsmedicales.fr/mesh/D000163#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Syndrome d'immunodéficience acquise",
"description": "Quels traitements existent pour le SIDA ?\nLes traitements du SIDA sont-ils curatifs ?\nÀ quelle fréquence faut-il prendre les médicaments ?\nQuels sont les effets secondaires des traitements ?\nLe traitement peut-il améliorer la qualité de vie ?",
"url": "https://questionsmedicales.fr/mesh/D000163#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Syndrome d'immunodéficience acquise",
"description": "Quelles sont les complications du SIDA ?\nLe SIDA peut-il entraîner des cancers ?\nComment le SIDA affecte-t-il la santé mentale ?\nQuelles infections sont fréquentes chez les patients SIDA ?\nLe SIDA peut-il affecter la fonction rénale ?",
"url": "https://questionsmedicales.fr/mesh/D000163#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Syndrome d'immunodéficience acquise",
"description": "Quels sont les principaux facteurs de risque du SIDA ?\nLes hommes ayant des rapports sexuels avec des hommes sont-ils à risque ?\nLe risque de SIDA est-il plus élevé chez les toxicomanes ?\nLes personnes ayant plusieurs partenaires sexuels sont-elles à risque ?\nLes femmes enceintes peuvent-elles transmettre le VIH ?",
"url": "https://questionsmedicales.fr/mesh/D000163#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment le SIDA est-il diagnostiqué ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le SIDA est diagnostiqué par des tests sanguins détectant le VIH et le taux de CD4."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le VIH ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests ELISA et les tests de charge virale sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quand faut-il se faire dépister pour le VIH ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est recommandé de se faire dépister après une exposition à risque ou annuellement."
}
},
{
"@type": "Question",
"name": "Quels sont les critères de diagnostic du SIDA ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le SIDA est diagnostiqué si le taux de CD4 est inférieur à 200 cellules/mm³ ou présence de maladies opportunistes."
}
},
{
"@type": "Question",
"name": "Le SIDA peut-il être diagnostiqué sans symptômes ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le SIDA peut être diagnostiqué par des tests même en l'absence de symptômes."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes du SIDA ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, fièvre, perte de poids, et infections fréquentes."
}
},
{
"@type": "Question",
"name": "Le SIDA cause-t-il des symptômes immédiats ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les symptômes peuvent prendre des années à apparaître après l'infection par le VIH."
}
},
{
"@type": "Question",
"name": "Comment les symptômes évoluent-ils ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes s'aggravent avec le temps, surtout si le traitement n'est pas suivi."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques aux infections opportunistes ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme la toux persistante ou des éruptions cutanées peuvent survenir."
}
},
{
"@type": "Question",
"name": "Le SIDA affecte-t-il le système nerveux ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut provoquer des troubles neurologiques comme la démence ou des troubles de la mémoire."
}
},
{
"@type": "Question",
"name": "Comment prévenir le SIDA ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut l'utilisation de préservatifs, le dépistage régulier et l'éducation."
}
},
{
"@type": "Question",
"name": "Le vaccin contre le VIH existe-t-il ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de vaccin efficace contre le VIH."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que la prophylaxie pré-exposition (PrEP) ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "La PrEP est un traitement préventif pour les personnes à haut risque d'infection par le VIH."
}
},
{
"@type": "Question",
"name": "Les transfusions sanguines sont-elles sûres ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les transfusions sont sûres grâce à des tests rigoureux pour le VIH."
}
},
{
"@type": "Question",
"name": "Comment réduire le risque de transmission ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des préservatifs, éviter le partage de seringues et se faire dépister régulièrement."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour le SIDA ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent les antirétroviraux qui aident à contrôler le virus et à renforcer le système immunitaire."
}
},
{
"@type": "Question",
"name": "Les traitements du SIDA sont-ils curatifs ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les traitements ne guérissent pas le SIDA mais contrôlent l'infection."
}
},
{
"@type": "Question",
"name": "À quelle fréquence faut-il prendre les médicaments ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les médicaments doivent être pris quotidiennement pour être efficaces."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des traitements ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure nausées, fatigue, et troubles digestifs."
}
},
{
"@type": "Question",
"name": "Le traitement peut-il améliorer la qualité de vie ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un traitement efficace peut améliorer la qualité de vie et prolonger l'espérance de vie."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications du SIDA ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des infections opportunistes, cancers et maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Le SIDA peut-il entraîner des cancers ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le SIDA augmente le risque de certains cancers, comme le sarcome de Kaposi."
}
},
{
"@type": "Question",
"name": "Comment le SIDA affecte-t-il la santé mentale ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le SIDA peut entraîner des troubles mentaux comme la dépression et l'anxiété."
}
},
{
"@type": "Question",
"name": "Quelles infections sont fréquentes chez les patients SIDA ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les infections fréquentes incluent la pneumonie, la tuberculose et les infections fongiques."
}
},
{
"@type": "Question",
"name": "Le SIDA peut-il affecter la fonction rénale ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le SIDA peut entraîner des complications rénales, y compris une insuffisance rénale."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque du SIDA ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux facteurs incluent les rapports sexuels non protégés, le partage de seringues et le VIH positif."
}
},
{
"@type": "Question",
"name": "Les hommes ayant des rapports sexuels avec des hommes sont-ils à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ce groupe est à risque accru en raison de la transmission sexuelle du VIH."
}
},
{
"@type": "Question",
"name": "Le risque de SIDA est-il plus élevé chez les toxicomanes ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le partage de seringues augmente considérablement le risque d'infection par le VIH."
}
},
{
"@type": "Question",
"name": "Les personnes ayant plusieurs partenaires sexuels sont-elles à risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, avoir plusieurs partenaires augmente le risque d'exposition au VIH."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes peuvent-elles transmettre le VIH ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le VIH peut être transmis de la mère à l'enfant pendant la grossesse, l'accouchement ou l'allaitement."
}
}
]
}
]
}
Beijing Tongren Eye Center, Beijing key Laboratory of Intraocular Tumor Diagnosis and Treatment, Beijing Ophthalmology and Visual Sciences Key Lab, Medical Artificial Intelligence Research and Verification Key Laboratory of the Ministry of Industry and Information Technology, Beijing Tongren Hospital, Capital Medical University, No.1 Dongjiaomin Lane, Dongcheng District, Beijing, 100730, China. weiwb1023@163.com.
Publications dans "Syndrome d'immunodéficience acquise" :
Department of Otolaryngology, Head and Neck Surgery, Loghman Hakim Educational Hospital School of medicine, Shahid Beheshti University of Medical Sciences Tehran Iran.
Skull base research center Loghman Hakim hospital, Shahid Beheshti University of Medical Sciences Tehran Iran.
Publications dans "Syndrome d'immunodéficience acquise" :
Histoplasmosis is caused by the fungus Histoplasma capsulatum and is often fatal for individuals with acquired immunodeficiency syndrome (AIDS). Delayed diagnosis is a major factor in worsening coinfe...
Aside from being a health issue, Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS) has an economic impact on Africa and Ghana in particular. Despite this, fewer empirical stud...
Cytomegalovirus retinitis (CMVR) is the most common and sight-threatening opportunistic retinal infection in patients with acquired immunodeficiency syndrome (AIDS) and several controversies remain to...
The databases PubMed, EMBASE, and Ovid from inception to April 2022 were searched to identify the relevant studies. R software version 3.6.3 was used to perform the statistical analyses. Results in pr...
We finally included 236 studies comprising 20,214 patients. CMVR in AIDS was male-dominated (88%, 95%CI 86%-89%), with 57% (95%CI 55%-60%) aged <41 years and 44% (95%CI 41%-47%) being bilaterally invo...
CMVR is a common opportunistic infection with diverse clinical features in AIDS patients, preponderant in those who are male, homosexual, or with CD4+ T-cells <50 cells/μL. Current therapies for CMVR ...
PROSPERO, identifier CRD42022363105....
Acquired immunodeficiency syndrome (AIDS) is associated with a high rate of pulmonary infections (bacteria, fungi, and viruses). To overcome the low sensitivity and long turnaround time of traditional...
This study enrolled 75 patients with AIDS and suspected pulmonary infections who were admitted to Nanning Fourth People's Hospital. Specimens were collected for traditional microbiological testing and...
In conclusion, mNGS analysis provides fast and precise pathogen detection and identification, contributing substantially to the accurate diagnosis, real-time monitoring, and treatment appropriateness ...
This study aimed to identify factors associated with late diagnosis and clinically monitor newly diagnosed HIV/AIDS patients....
Retrospective study, based on secondary data from a specialized unit at the Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto of the University of Sao Paulo. Data collection included so...
A total of 314 individuals were newly diagnosed with HIV/AIDS, 86.6% (272) had a late diagnosis and 53.8% (169) were diagnosed very late. Using the adjusted odds ratio, we observed that bisexual and M...
This study evidenced a high prevalence of late and very late diagnoses. Therefore, attention should be directed towards factors related to late and very late presentation....
Progressive multifocal leukoencephalopathy (PML) - immune reconstitution inflammatory syndrome (IRIS) in people living with HIV/AIDS (PLWHA) has been rarely described in low- and middle-income countri...
To describe the prevalence of PML-IRIS among PLWHA with PML and its main features in a tertiary hospital in Brazil....
We performed a retrospective cohort study. We included PLWHA with PML-IRIS patients admitted at...
We identified 11 (11.8%) PML-IRIS cases among 93 patients with definite PML. Eight (73%) cases were men and had a median (IQR) age of 41 (27-50) years. Seven (63.6%) patients developed unmasking PML-I...
The prevalence of PML-IRIS was 11.8%. Most patients had unmasking PML-IRIS. In-hospital mortality and morbidity were high. One-year survival was similar to that described in some high-income countries...
Ritonavir and darunavir were examined using a ultra-performance liquid chromatography (UPLC) approach in pharmaceutical dosage forms. The small number of analytical studies that are currently availabl...
Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening disease characterized by a hyperinflammatory syndrome and impairment of multiple organ systems. Talaromycosis marneffei (TSM) is an oppor...
Moyamoya angiopathy is a rare cerebrovascular condition characterized by insufficient cerebral blood flow resulting from arterial vessel narrowing or occlusion, potentially leading to cerebral ischemi...
The global challenge posed by the human immunodeficiency virus (HIV) and its manifestation as acquired immunodeficiency syndrome (AIDS) is underscored by the prevalence of 5.9 million people living wi...